GO:0044224 juxtaparanode region of axon: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044224 (juxtaparanode region of axon) is a cellular component located between the paranode and internode regions of myelinated axons, adjacent to the node of Ranvier.
• The juxtaparanode is enriched in voltage-gated potassium channels (Kv1.1, Kv1.2) and their auxiliary subunits, which help stabilize the axon and regulate excitability.
• Key proteins at the juxtaparanode include CASPR2 (CNTNAP2), TAG-1 (CNTN2), and Kv1 channels, which are anchored by cytoskeletal scaffolds such as 4.1B and ankyrin.
• Disruption of juxtaparanodal components is linked to neurological disorders including neuromyotonia, chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), and other neuropathies.
• Research on the juxtaparanode uses advanced imaging, electrophysiology, and CRISPR-based gene editing to dissect its molecular organization and function.
• Understanding the juxtaparanode is crucial for developing therapies targeting demyelinating diseases and channelopathies.
Description
The juxtaparanode region of axon (GO:0044224) is a specialized domain of myelinated axons that lies between the paranode and the internode, immediately adjacent to the node of Ranvier. This region is critical for the proper clustering of voltage-gated potassium channels and for maintaining axonal excitability and conduction. Researchers study the juxtaparanode to understand how its molecular architecture contributes to normal nerve function and how its disruption leads to neurological disorders. The juxtaparanode is defined by the presence of specific cell adhesion molecules and cytoskeletal adaptors that anchor ion channels and signaling proteins. Its unique composition distinguishes it from the node, paranode, and internode, making it a key area for investigating axon-glia interactions and demyelinating pathologies.
juxtaparanode region of axon At A Glance
| GO ID | GO:0044224 |
|---|---|
| GO term | juxtaparanode region of axon |
| Ontology | cellular_component |
| Synonym | juxtaparanodal region, juxtaparanode, juxta paranode axon |
| Major function | Clustering of voltage-gated potassium channels and regulation of axonal excitability |
| Location | Axon, between paranode and internode, adjacent to node of Ranvier |
| Key proteins | Kv1.1, Kv1.2, CASPR2, TAG-1, 4.1B, Ankyrin |
| Associated diseases | Neuromyotonia, CIDP, neuropathies |
What Is GO:0044224?
The juxtaparanode region of axon is a cellular component defined by the Gene Ontology as the region of an axon near a node of Ranvier that is located between the paranode and the internode regions. It is a distinct microdomain characterized by the accumulation of voltage-gated potassium channels and associated proteins, which are essential for regulating axonal excitability and maintaining the structural integrity of the myelinated axon.
Why Is juxtaparanode region of axon Important in Cell Biology?
The juxtaparanode region is essential for normal nerve conduction because it houses voltage-gated potassium channels that repolarize the axon after an action potential. Disruption of this domain leads to hyperexcitability and neurological disorders such as neuromyotonia and demyelinating neuropathies. Studying the juxtaparanode provides insights into axon-glia interactions and the pathophysiology of myelin-related diseases.
• Regulates axonal excitability by clustering Kv1 potassium channels.
• Maintains the structural integrity of the myelinated axon.
• Involved in the pathophysiology of demyelinating diseases like CIDP.
• Target of autoantibodies in neuromyotonia and related disorders.
• Provides a model for studying axon-glia interactions.
• Key to understanding channelopathies and nerve conduction defects.
• Potential therapeutic target for neuropathic pain and hyperexcitability.
• Requires precise molecular assembly for proper function.
Structure and Composition of juxtaparanode region of axon
Definition and Location
In simple terms: The juxtaparanode is a specific zone on the axon just outside the node of Ranvier.
The juxtaparanode region of axon is located between the paranode and the internode, adjacent to the node of Ranvier. It is a distinct microdomain that can be identified by the presence of voltage-gated potassium channels and associated cell adhesion molecules.
Voltage-Gated Potassium Channels
In simple terms: Potassium channels sit in the juxtaparanode to help control electrical signals.
The juxtaparanode is enriched in Kv1.1 and Kv1.2 channels, which are clustered together with their auxiliary subunits Kvβ2 and Kvβ1. These channels are critical for repolarizing the axon and preventing repetitive firing.
Cell Adhesion Molecules
In simple terms: Sticky proteins hold the potassium channels in place.
CASPR2 (CNTNAP2) and TAG-1 (CNTN2) are key cell adhesion molecules that mediate the clustering of Kv1 channels at the juxtaparanode. They interact with cytoskeletal adaptors to stabilize the domain.
Cytoskeletal Scaffolding
In simple terms: The internal skeleton of the axon anchors the channels.
The submembranous cytoskeleton, including protein 4.1B and ankyrin, provides a scaffold that anchors Kv1 channels and cell adhesion molecules at the juxtaparanode. This scaffolding is essential for maintaining the domain's integrity.
Key Genes Involved in GO:0044224 juxtaparanode region of axon
The following genes encode proteins that are critical for the structure and function of the juxtaparanode region of axon.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CNTNAP2 | Encodes CASPR2, a cell adhesion molecule that clusters Kv1 channels | Mutations linked to neuromyotonia and neurodevelopmental disorders |
| CNTN2 | Encodes TAG-1, a GPI-anchored adhesion molecule | Involved in axon-glia interactions and juxtaparanodal assembly |
| KCNA1 | Encodes Kv1.1 potassium channel subunit | Mutations cause episodic ataxia and neuromyotonia |
| KCNA2 | Encodes Kv1.2 potassium channel subunit | Key component of juxtaparanodal Kv1 channels |
| KCNB1 | Encodes Kv2.1 potassium channel | May contribute to juxtaparanodal excitability |
| EPB41L3 | Encodes protein 4.1B, a cytoskeletal adaptor | Anchors Kv1 channels at juxtaparanode |
| ANK3 | Encodes ankyrin-G, a cytoskeletal protein | Involved in node and juxtaparanode organization |
| SCN1A | Encodes Nav1.1 sodium channel | Not directly at juxtaparanode but relevant for excitability |
| SCN2A | Encodes Nav1.2 sodium channel | Expressed in premyelinated axons, may influence juxtaparanode |
| LGI1 | Encodes leucine-rich glioma-inactivated protein 1 | Autoantibody target in limbic encephalitis, interacts with CASPR2 |
| ADAM22 | Encodes a metalloprotease that interacts with LGI1 | Part of the juxtaparanodal complex |
| ADAM23 | Encodes a metalloprotease that interacts with LGI1 | May regulate Kv1 channel clustering |
| MPZ | Encodes myelin protein zero | Mutations cause Charcot-Marie-Tooth disease, affecting juxtaparanode |
| PMP22 | Encodes peripheral myelin protein 22 | Duplication causes CMT1A, disrupts juxtaparanode |
| GJB1 | Encodes connexin 32 | Mutations cause X-linked CMT, affecting axon-glia junctions |
| MAG | Encodes myelin-associated glycoprotein | Involved in axon-glia interactions at juxtaparanode |
| NFASC | Encodes neurofascin | Critical for node and paranode assembly, influences juxtaparanode |
How Is juxtaparanode region of axon Regulated?
The assembly and maintenance of the juxtaparanode region are regulated by axon-glia interactions and intracellular signaling pathways. Myelinating glia provide signals that direct the clustering of Kv1 channels and cell adhesion molecules. Cytoskeletal adaptors such as 4.1B and ankyrin are regulated by phosphorylation and interactions with other proteins. Disruption of these regulatory mechanisms leads to mislocalization of juxtaparanodal components and altered excitability.
juxtaparanode region of axon and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CNTNAP2 | Neuromyotonia, CASPR2 antibody-associated disorders | Knockout mouse, patient-derived iPSC neurons |
| KCNA1 | Episodic ataxia type 1, neuromyotonia | Point mutation knock-in mouse |
| MPZ | Charcot-Marie-Tooth disease type 1B | Knock-in mouse with MPZ mutation |
| PMP22 | Charcot-Marie-Tooth disease type 1A | Transgenic overexpression rat |
| GJB1 | X-linked Charcot-Marie-Tooth disease | Knockout mouse |
Neuromyotonia and CASPR2 Antibodies
Autoantibodies against CASPR2 (encoded by CNTNAP2) disrupt the juxtaparanode, leading to neuromyotonia and related disorders characterized by peripheral nerve hyperexcitability. These antibodies target the extracellular domain of CASPR2, impairing Kv1 channel clustering and causing continuous muscle fiber activity.
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
In CIDP, the juxtaparanode and initial axon segments are disrupted, contributing to conduction block and weakness. Pathological changes include redistribution of Kv1 channels and detachment of myelin, which alter axonal excitability.
Neuropathies and Channelopathies
Mutations in KCNA1, encoding Kv1.1, cause episodic ataxia type 1 and neuromyotonia, highlighting the importance of juxtaparanodal potassium channels. Other neuropathies, such as Charcot-Marie-Tooth disease, involve disruption of axon-glia interactions that affect the juxtaparanode.
From juxtaparanode region of axon-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of CASPR2 in Kv1 channel clustering? | CNTNAP2 knockout mouse |
| How do KCNA1 mutations affect juxtaparanodal function? | KCNA1 point mutation knock-in mouse |
| Does overexpression of TAG-1 alter juxtaparanode assembly? | TAG-1 transgenic overexpression mouse |
| How does loss of 4.1B affect juxtaparanodal structure? | EPB41L3 knockout mouse |
| Can CRISPR-mediated correction of MPZ restore juxtaparanode? | MPZ knock-in correction in iPSC-derived neurons |
| What is the effect of anti-CASPR2 antibodies on juxtaparanode? | Passive transfer model in mice |
How to Study the juxtaparanode region of axon Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Immunofluorescence | Localization of juxtaparanodal proteins | Assess domain integrity in disease models |
| Super-resolution microscopy | Nanoscale organization of Kv1 channels | Study clustering mechanisms |
| Patch-clamp electrophysiology | Potassium currents and excitability | Functional analysis of mutations |
| Nerve conduction studies | Conduction velocity and block | Diagnosis of neuropathies |
| CRISPR knockout | Gene function loss | Identify essential juxtaparanodal genes |
| Proteomics | Protein composition of juxtaparanode | Discover novel interactors |
| RNA-seq | Gene expression changes | Compare wild-type and mutant axons |
Imaging of Juxtaparanodal Proteins
Immunofluorescence and super-resolution microscopy can visualize the localization of Kv1 channels, CASPR2, and TAG-1 at the juxtaparanode. These methods reveal domain organization and disruption in disease models.
Electrophysiology
Patch-clamp and nerve conduction studies measure the functional consequences of juxtaparanodal disruption, such as altered potassium currents and hyperexcitability.
CRISPR-Based Gene Editing
CRISPR/Cas9 can generate knockout, point mutation, and knock-in models to study the role of specific genes in juxtaparanode formation and function.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify protein complexes at the juxtaparanode, revealing novel components and interactions.
How CRISPR Can Be Used to Study GO:0044224 juxtaparanode region of axon
Knockout
CRISPR knockout of genes such as CNTNAP2 or KCNA1 in mice or cell models can reveal their essential roles in juxtaparanode assembly and function. Knockout models help determine causality and identify compensatory mechanisms.
Point Mutation
Introducing disease-associated point mutations (e.g., in KCNA1) using CRISPR allows precise modeling of channelopathies and assessment of their impact on juxtaparanodal excitability.
Knock-in
Knock-in of tagged proteins (e.g., GFP-tagged CASPR2) enables live imaging and biochemical isolation of juxtaparanodal complexes. This approach facilitates tracking of protein dynamics.
Overexpression
Overexpression of genes like TAG-1 or Kv1.2 can test sufficiency for domain formation and identify downstream effects on axon-glia interactions.
How EDITGENE Supports juxtaparanode region of axon Research
Researchers studying juxtaparanode region of axon-related genes often need to determine whether a candidate gene is causally involved in domain assembly, maintenance, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for juxtaparanode region of axon research.
Frequently Asked Questions About juxtaparanode region of axon
What is the juxtaparanode region of axon?
The juxtaparanode region of axon (GO:0044224) is a specialized domain of myelinated axons located between the paranode and internode, adjacent to the node of Ranvier, enriched in voltage-gated potassium channels.
What genes are involved in the juxtaparanode region of axon?
Key genes include CNTNAP2 (CASPR2), CNTN2 (TAG-1), KCNA1 (Kv1.1), KCNA2 (Kv1.2), and EPB41L3 (protein 4.1B).
What is the function of the juxtaparanode?
It clusters Kv1 potassium channels to regulate axonal excitability and repolarization after action potentials.
How is the juxtaparanode related to neurological diseases?
Disruption of juxtaparanodal proteins is linked to neuromyotonia, CIDP, and other neuropathies.
What proteins are enriched at the juxtaparanode?
Kv1.1, Kv1.2, CASPR2, TAG-1, protein 4.1B, and ankyrin are enriched at the juxtaparanode.
How can I study the juxtaparanode using CRISPR?
CRISPR can generate knockout, point mutation, and knock-in models to dissect gene function in juxtaparanode assembly and disease.
What is the difference between node, paranode, and juxtaparanode?
The node is the gap between myelin sheaths; the paranode flanks the node and anchors myelin; the juxtaparanode lies beyond the paranode and clusters potassium channels.
Which diseases involve CASPR2 antibodies?
CASPR2 antibodies are associated with neuromyotonia and limbic encephalitis, targeting the juxtaparanode.
What model organisms are used to study the juxtaparanode?
Mice, rats, and patient-derived iPSCs are commonly used, with CRISPR editing to introduce mutations.
How does the juxtaparanode contribute to nerve conduction?
By clustering potassium channels, it helps repolarize the axon and prevents aberrant firing.
Conclusion
The juxtaparanode region of axon (GO:0044224) is a critical microdomain that ensures proper nerve conduction by organizing potassium channels and cell adhesion molecules. Its disruption underlies several neurological disorders, making it a key focus for research. Advances in CRISPR gene editing and imaging technologies continue to unravel its molecular complexity, offering hope for targeted therapies.
References
- 1. Fehmi J et al.. 2018. Nodes, paranodes and neuropathies.. J Neurol Neurosurg Psychiatry 89(1):61-71 PMID: 28819062
- 2. Dziadkowiak E et al.. 2022. Pathology of Initial Axon Segments in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders.. Int J Mol Sci 23(21) PMID: 36362407
- 3. Eshed-Eisenbach Y et al.. 2023. Nodes of Ranvier in health and disease.. J Peripher Nerv Syst 28 Suppl 3:S3-S11 PMID: 37272548
- 4. Susuki K et al.. 2016. Submembranous cytoskeletons stabilize nodes of Ranvier.. Exp Neurol 283(Pt B):446-51 PMID: 26775177
- 5. Arancibia-Carcamo IL et al.. 2014. The node of Ranvier in CNS pathology.. Acta Neuropathol 128(2):161-75 PMID: 24913350
- 6. Peles E et al.. 2000. Molecular domains of myelinated axons.. Curr Opin Neurobiol 10(5):558-65 PMID: 11084317
- 7. Moura J et al.. 2025. Neuromyotonia and CASPR2 Antibodies: Electrophysiological Clues to Disease Pathophysiology.. Biomolecules 15(9) PMID: 41008569
- 8. Gennarini G et al.. 2017. The role of Gpi-anchored axonal glycoproteins in neural development and neurological disorders.. Mol Cell Neurosci 81:49-63 PMID: 27871938
